Gilead helps Nasdaq rebound on coronavirus news 
 The Nasdaq composite is back in the green, up   from its intraday low, helped by the rally in Gilead Sciences (GILD ) on 30% higher volume on reports that it is evaluating its experimental Ebola candidate, Nuc inhibitor GS-5734, for the potential treatment of 2019-nCov infection, the coronavirus causing the current outbreak in China.